[1]
Tremezaygues L, Sticherling M, Pföhler C, et al. Cutaneous photosynthesis of vitamin D: An evolutionary highly-conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections. Anticancer Res 2006; 26(4A): 2743-8. [PMID: 16886686].
[2]
Holick MF, Vitamin D. Evolutionary, physiological and health perspectives. Curr Drug Targets 2011; 12(1): 4-18. [http://dx.doi.org/10.2174/138945011793591635]. [PMID: 20795941].
[3]
Holick MF, Vitamin D. A millenium perspective. J Cell Biochem 2003; 88(2): 296-307. [http://dx.doi.org/10.1002/jcb.10338]. [PMID: 12520530].
[4]
McMollum EV, Simmonds N, Becker JE, Shipley PG. Studies on experimental rickets: An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922; 52: 293-8.
[5]
Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: A historical perspective. Pediatrics 2003; 112(2): E132-5. [http://dx.doi.org/10.1542/peds.112.2.e132]. [PMID: 12897318].
[6]
Holick MF. The cutaneous photosynthesis of previtamin D3: A unique photoendocrine system. J Invest Dermatol 1981; 77(1): 51-8. [http://dx.doi.org/10.1111/1523-1747.ep12479237]. [PMID: 6265564].
[7]
Carlberg C. Molecular approaches for optimizing vitamin D supplementation. Vitam Horm 2016; 100: 255-71. [http://dx.doi.org/10.1016/bs.vh.2015.10.001]. [PMID: 26827955].
[8]
Bendik I, Friedel A, Roos FF, Weber P, Eggersdorfer M, Vitamin D. A critical and essential micronutrient for human health. Front Physiol 2014; 5: 248. [http://dx.doi.org/10.3389/fphys.2014.00248]. [PMID: 25071593].
[9]
Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135(2): 317-22. [http://dx.doi.org/10.1093/jn/135.2.317]. [PMID: 15671234].
[10]
Slominski AT, Kim TK, Takeda Y, et al. RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J 2014; 28(7): 2775-89. [http://dx.doi.org/10.1096/fj.13-242040]. [PMID: 24668754].
[11]
Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: The second decade. Cell 1995; 83(6): 835-9. [http://dx.doi.org/10.1016/0092-8674(95)90199-X]. [PMID: 8521507].
[12]
Turunen MM, Dunlop TW, Carlberg C, Väisänen S. Selective use of multiple vitamin D response elements underlies the 1 α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res 2007; 35(8): 2734-47. [http://dx.doi.org/10.1093/nar/gkm179]. [PMID: 17426122].
[13]
Bouillon R, Suda T, Vitamin D. Calcium and bone homeostasis during evolution. Bonekey Rep 2014; 3: 480. [http://dx.doi.org/10.1038/bonekey.2013.214]. [PMID: 24466411].
[14]
Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol Cell Endocrinol 2017; 453: 36-45. [http://dx.doi.org/10.1016/j.mce.2017.04.008]. [PMID: 28400273].
[15]
van de Peppel J, van Leeuwen JP. Vitamin D and gene networks in human osteoblasts. Front Physiol 2014; 5: 137. [http://dx.doi.org/10.3389/fphys.2014.00137]. [PMID: 24782782].
[16]
Marks J, Debnam ES, Unwin RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 2010; 299(2): F285-96. [http://dx.doi.org/10.1152/ajprenal.00508.2009]. [PMID: 20534868].
[17]
Kim S, Yamazaki M, Zella LA, et al. Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2007; 103(3-5): 430-4. [http://dx.doi.org/10.1016/j.jsbmb.2006.12.020]. [PMID: 17197168].
[18]
Feldman DJ, Malloy P. Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep 2014; 3: 510. [http://dx.doi.org/10.1038/bonekey.2014.5]. [PMID: 24818002].
[19]
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14(5): 342-57. [http://dx.doi.org/10.1038/nrc3691]. [PMID: 24705652].
[20]
Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front Physiol 2014; 5: 151. [http://dx.doi.org/10.3389/fphys.2014.00151]. [PMID: 24795646].
[21]
Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 2012; 108(9): 1557-61. [http://dx.doi.org/10.1017/S0007114511007161]. [PMID: 22264449].
[22]
Hochberg Z, Templeton AR. Evolutionary perspective in skin color, vitamin D and its receptor. Hormones (Athens) 2010; 9(4): 307-11. [http://dx.doi.org/10.14310/horm.2002.1281]. [PMID: 21112861].
[23]
Jablonski NG, Chaplin G. The roles of vitamin D and cutaneous vitamin D production in human evolution and health. Int J Paleopathol 2018; 23: 54-9. [http://dx.doi.org/10.1016/j.ijpp.2018.01.005]. [PMID: 29606375].
[24]
Carlberg C. The physiology of vitamin D-far more than calcium and bone. Front Physiol 2014; 5: 335. [http://dx.doi.org/10.3389/fphys.2014.00335]. [PMID: 25228886].
[25]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81. [http://dx.doi.org/10.1056/NEJMra070553]. [PMID: 17634462].
[26]
Schwartz GG. Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology 1992; 11(4-6): 244-54. [http://dx.doi.org/10.1159/000110937]. [PMID: 1291888].
[27]
Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press 2011.
[28]
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22(4): 477-501. [http://dx.doi.org/10.1210/edrv.22.4.0437]. [PMID: 11493580].
[29]
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30. [http://dx.doi.org/10.1210/jc.2011-0385]. [PMID: 21646368].
[30]
Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: Critical need for revision upwards. J Nutr 2006; 136(4): 1117-22. [http://dx.doi.org/10.1093/jn/136.4.1117]. [PMID: 16549491].
[31]
Carlberg C, Seuter S, de Mello VD, et al. Primary vitamin D target genes allow a categorization of possible benefits of vitamin D3 supplementation. PLoS One 2013; 8(7)e71042 [http://dx.doi.org/10.1371/journal.pone.0071042]. [PMID: 23923049].
[32]
Wilfinger J, Seuter S, Tuomainen T-P, et al. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. J Nutr Biochem 2014; 25(8): 875-84. [http://dx.doi.org/10.1016/j.jnutbio.2014.04.002]. [PMID: 24854954].
[33]
Ryynänen J, Neme A, Tuomainen TP, et al. Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol Nutr Food Res 2014; 58(10): 2036-45. [http://dx.doi.org/10.1002/mnfr.201400291]. [PMID: 24975273].
[34]
Saksa N, Neme A, Ryynänen J, et al. Dissecting high from low responders in a vitamin D3 intervention study. J Steroid Biochem Mol Biol 2015; 148: 275-82. [http://dx.doi.org/10.1016/j.jsbmb.2014.11.012]. [PMID: 25448738].
[35]
Vukić M, Neme A, Seuter S, et al. Relevance of vitamin D receptor target genes for monitoring the vitamin D responsiveness of primary human cells. PLoS One 2015; 10(4)e0124339 [http://dx.doi.org/10.1371/journal.pone.0124339]. [PMID: 25875760].
[36]
Seuter S, Virtanen JK, Nurmi T, et al. Molecular evaluation of vitamin D responsiveness of healthy young adults. J Steroid Biochem Mol Biol 2017; 174: 314-21. [http://dx.doi.org/10.1016/j.jsbmb.2016.06.003]. [PMID: 27282116].
[37]
Carlberg C, Haq A. The concept of the personal vitamin D response index. J Steroid Biochem Mol Biol 2018; 175: 12-7. [http://dx.doi.org/10.1016/j.jsbmb.2016.12.011]. [PMID: 28034764].
[38]
Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2 vitamin D3: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 543-59. [http://dx.doi.org/10.1016/j.beem.2011.05.010]. [PMID: 21872797].
[39]
Ordóñez-Morán P, Larriba MJ, Pálmer HG, et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 2008; 183(4): 697-710. [http://dx.doi.org/10.1083/jcb.200803020]. [PMID: 19015318].
[40]
Haussler MR, Haussler CA, Jurutka PW, et al. The vitamin D hormone and its nuclear receptor: Molecular actions and disease states. J Endocrinol 1997; 154(Suppl.): S57-73. [PMID: 9379138].
[41]
Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: Function, expression and evolution. Nat Rev Genet 2009; 10(4): 252-63. [http://dx.doi.org/10.1038/nrg2538]. [PMID: 19274049].
[42]
Molnár F, Peräkylä M, Carlberg C. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J Biol Chem 2006; 281(15): 10516-26. [http://dx.doi.org/10.1074/jbc.M513609200]. [PMID: 16478719].
[43]
Herdick M, Carlberg C. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. J Mol Biol 2000; 304(5): 793-801. [http://dx.doi.org/10.1006/jmbi.2000.4267]. [PMID: 11124027].
[44]
Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C. VDR-Alien: A novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J 2000; 14(10): 1455-63. [http://dx.doi.org/10.1096/fasebj.14.10.1455]. [PMID: 10877839].
[45]
Pereira F, Barbáchano A, Singh PK, Campbell MJ, Muñoz A, Larriba MJ. Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 2012; 11(6): 1081-9. [http://dx.doi.org/10.4161/cc.11.6.19508]. [PMID: 22370479].
[46]
Molnár F. Structural considerations of vitamin D signaling. Front Physiol 2014; 5: 191. [http://dx.doi.org/10.3389/fphys.2014.00191]. [PMID: 24936188].
[47]
Wei Z, Yoshihara E, He N, et al. Vitamin D switches BAF complexes to protect beta cells. Cell 2018; 173: 1135-49 e15.
[48]
Pereira F, Barbáchano A, Silva J, et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet 2011; 20(23): 4655-65. [http://dx.doi.org/10.1093/hmg/ddr399]. [PMID: 21890490].
[49]
Carlberg C, Bendik I, Wyss A, et al. Two nuclear signalling pathways for vitamin D. Nature 1993; 361(6413): 657-60. [http://dx.doi.org/10.1038/361657a0]. [PMID: 8382345].
[50]
Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res 2010; 20(10): 1352-60. [http://dx.doi.org/10.1101/gr.107920.110]. [PMID: 20736230].
[51]
Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 2011; 39(21): 9181-93. [http://dx.doi.org/10.1093/nar/gkr654]. [PMID: 21846776].
[52]
Tuoresmäki P, Väisänen S, Neme A, Heikkinen S, Carlberg C. Patterns of genome-wide VDR locations. PLoS One 2014; 9(4)e96105 [http://dx.doi.org/10.1371/journal.pone.0096105]. [PMID: 24787735].
[53]
Meyer MB, Goetsch PD, Pike JW. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: Impact on c-FOS and c-MYC gene expression. Mol Endocrinol 2012; 26(1): 37-51. [http://dx.doi.org/10.1210/me.2011-1109]. [PMID: 22108803].
[54]
Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013; 153(3): 601-13. [http://dx.doi.org/10.1016/j.cell.2013.03.028]. [PMID: 23622244].
[55]
Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front Physiol 2014; 5: 167. [http://dx.doi.org/10.3389/fphys.2014.00167]. [PMID: 24808867].
[56]
Neme A, Seuter S, Carlberg C. Selective regulation of biological processes by vitamin D based on the spatio-temporal cistrome of its receptor. Biochim Biophys Acta Gene Regul Mech 2017; 1860(9): 952-61. [http://dx.doi.org/10.1016/j.bbagrm.2017.07.002]. [PMID: 28712921].
[57]
Campbell MJ. Vitamin D and the RNA transcriptome: More than mRNA regulation. Front Physiol 2014; 5: 181. [http://dx.doi.org/10.3389/fphys.2014.00181]. [PMID: 24860511].
[58]
Waddington CH. Canalization of development and the inheritance of acquired characters. Nature 1942; 150: 563-5. [http://dx.doi.org/10.1038/150563a0].
[59]
Wu Ct, Morris JR. Genes, genetics, and epigenetics: A correspondence. Science 2001; 293(5532): 1103-5. [http://dx.doi.org/10.1126/science.293.5532.1103]. [PMID: 11498582].
[60]
Beisel C, Paro R. Silencing chromatin: Comparing modes and mechanisms. Nat Rev Genet 2011; 12(2): 123-35. [http://dx.doi.org/10.1038/nrg2932]. [PMID: 21221116].
[61]
Carlberg C, Molnár F. The epigenome Mechanisms of Gene Regulation. 2nd ed. Springer 2016; pp. 159-72.
[62]
Dawson MA, Kouzarides T. Cancer epigenetics: From mechanism to therapy. Cell 2012; 150(1): 12-27. [http://dx.doi.org/10.1016/j.cell.2012.06.013]. [PMID: 22770212].
[63]
Carlberg C, Molnár F. The Impact of Chromatin Mechanisms of Gene Regulation. 2nd ed. Springer 2016; pp. 17-34.
[64]
Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 2013; 20(3): 259-66. [http://dx.doi.org/10.1038/nsmb.2470]. [PMID: 23463310].
[65]
Deans C, Maggert KA. What do you mean, “epigenetic”? Genetics 2015; 199(4): 887-96. [http://dx.doi.org/10.1534/genetics.114.173492]. [PMID: 25855649].
[66]
Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor. Steroids 2013; 78(2): 127-36. [http://dx.doi.org/10.1016/j.steroids.2012.10.019]. [PMID: 23178257].
[67]
Nurminen V, Neme A, Seuter S, Carlberg C. The impact of the vitamin D-modulated epigenome on VDR target gene regulation. Biochim Biophys Acta Gene Regul Mech 2018; 1861(8): 697-705. [http://dx.doi.org/10.1016/j.bbagrm.2018.05.006]. [PMID: 30018005].
[68]
An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489(7414): 57-74. [http://dx.doi.org/10.1038/nature11247]. [PMID: 22955616].
[69]
Seuter S, Neme A, Carlberg C. Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF. Nucleic Acids Res 2016; 44(9): 4090-104. [PMID: 26715761].
[70]
Carlberg C, Seuter S, Nurmi T, Tuomainen TP, Virtanen JK, Neme A. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. J Steroid Biochem Mol Biol 2018; 180: 142-8. [http://dx.doi.org/10.1016/j.jsbmb.2018.01.002]. [PMID: 29317287].
[71]
Neme A, Seuter S, Carlberg C. Vitamin D-dependent chromatin association of CTCF in human monocytes. Biochim Biophys Acta 2016; 1859(11): 1380-8. [http://dx.doi.org/10.1016/j.bbagrm.2016.08.008]. [PMID: 27569350].
[72]
Seuter S, Neme A, Carlberg C. Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling. Biochim Biophys Acta Gene Regul Mech 2017; 1860(4): 405-15. [http://dx.doi.org/10.1016/j.bbagrm.2017.02.005]. [PMID: 28232093].
[73]
Seuter S, Neme A, Carlberg C. Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF. Nucleic Acids Res 2016; 44(9): 4090-104. [http://dx.doi.org/10.1093/nar/gkv1519]. [PMID: 26715761].
[74]
Dixon JR, Selvaraj S, Yue F, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012; 485(7398): 376-80. [http://dx.doi.org/10.1038/nature11082]. [PMID: 22495300].
[75]
Ali T, Renkawitz R, Bartkuhn M. Insulators and domains of gene expression. Curr Opin Genet Dev 2016; 37: 17-26. [http://dx.doi.org/10.1016/j.gde.2015.11.009]. [PMID: 26802288].
[76]
Carlberg C. Molecular endocrinology of vitamin D on the epigenome level. Mol Cell Endocrinol 2017; 453: 14-21. [http://dx.doi.org/10.1016/j.mce.2017.03.016]. [PMID: 28315703].
[77]
Verstuyf A, Carmeliet G, Bouillon R, Mathieu C, Vitamin D. A pleiotropic hormone. Kidney Int 2010; 78(2): 140-5. [http://dx.doi.org/10.1038/ki.2010.17]. [PMID: 20182414].